March 18 Product: Orchard Therapeutics Lenmeldy Indication: Metachromatic leukodystrophy Monday, the FDA gave a glimmer of hope to families of children with metachromatic leukodystrophy (MLD), a rare genetic disease affecting the brain and nervous system, with the approval of Orchard Therapeutics Lenmeldy
Visit us at our Pinecrest location to shop the entire line of ZO Skin Health products
X chromosome protects against bladder cancer in females via a KDM6A-dependent epigenetic mechanism
Treat switching as an upgrade, not a rescue
Informed Consent: The present study followed the Declaration of Helsinki, and written informed consent was obtained from all the participants
30+ years of safety research, zero tumor evidence, plus risk factors to consider before use